Keyphrases
ANCA-associated Vasculitis
33%
Antineutrophil Cytoplasmic Antibody
33%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
100%
Atrophy
33%
Birmingham Vasculitis Activity Score
33%
Cataract
33%
Confidence Interval
33%
Diabetes
66%
Elderly Onset
100%
Elderly Patients
33%
High Dose
66%
Hypertension
33%
Inception Cohort Study
33%
Index Score
66%
Intergroup Difference
33%
Logistic Regression Analysis
33%
MPO-ANCA
33%
Odds Ratio
33%
Osteoporosis
33%
Outcome Analysis
100%
Patient Characteristics
33%
Patient Outcomes
33%
Prednisolone
100%
Prospective Cohort Study
100%
Rapid Reduction
33%
Remission
66%
Safe Treatment
33%
Safety Outcomes
100%
Serious Infection
66%
Serum Creatinine Level
33%
Treatment-related
100%
Vasculitis Damage Index
100%
Medicine and Dentistry
ANCA Associated Vasculitis
100%
Cataract
25%
Cohort Analysis
25%
Creatinine
25%
Diabetes
50%
Drug Megadose
50%
Elderly Patient
25%
Glucocorticoid
75%
Infection
50%
Logistic Regression Analysis
25%
Low Drug Dose
75%
Myeloblastin
25%
Myeloperoxidase
25%
Neutrophil Cytoplasmic Antibody
50%
Odds Ratio
25%
Osteoporosis
25%
Patient Characteristics
25%
Prednisolone
75%
Prospective Cohort Study
100%
Vasculitis
100%
Weakness
25%
Pharmacology, Toxicology and Pharmaceutical Science
ANCA Associated Vasculitis
100%
Cataract
25%
Cohort Study
25%
Creatinine
25%
Glucocorticoid
75%
Infection
50%
Myeloblastin
25%
Myeloperoxidase
25%
Neutrophil Cytoplasmic Antibody
50%
Prednisolone
75%
Prospective Cohort Study
100%
Remission
50%
Vasculitis
100%
Weakness
25%
Immunology and Microbiology
ANCA Associated Vasculitis
100%
Creatinine Blood Level
25%
Drug Megadose
50%
Glucocorticoid
75%
Low Drug Dose
75%
Neutrophil Cytoplasmic Antibody
50%
Prednisolone
75%
Vasculitis
100%